HUANG, Xulin. Recent Advances of Drug Design Strategies for Classical KRAS Mutations. Transactions on Materials, Biotechnology and Life Sciences, [S. l.], v. 4, p. 88–93, 2024. DOI: 10.62051/yc6p5d86. Disponível em: https://wepub.org/index.php/TMBLS/article/view/2997. Acesso em: 13 may. 2026.